Composition:
Polyfructosans - oligofructose (fructooligosaccharides) and inulin (fructopolysaccharides); vitamin and mineral premix "Immunity" (vitamins C, E, B1, B2, PP, B5, B6, B12, folic acid, biotin, zinc and selenium), as well as starch, aerosil and calcium stearate.
Description:
STIMBIFID restores the individual intestinal microbiota, creating first priority conditions for the reproduction of bifidobacteria, and later for lactobacilli and Escherichia coli, which, inhibiting the growth of pathogenic microflora, displace it from the body. Raftilin and Raftilose included in STIMBIFID are highly purified natural fructooligosaccharide and fructopolysaccharide fibers. It is they who form favorable conditions in the intestine, in which the patient's own (individual) bifidobacteria multiply. Vegetable fibers - fructopolysaccharides (inulin) and fructooligosaccharides (oligofructose) derived from them are found in many fruit and vegetable crops, and thus have been part of our daily diet for many centuries. They are not digested in the stomach and small intestine and reach the large intestine practically unchanged, where they selectively stimulate the growth of beneficial bifidobacteria. Thus, inulin and oligofructose are exclusive food for bifidobacteria - the main component of the obligate intestinal microbiota. The specially developed formula of Stimbifid containing a unique composition of long (GFn, n = 2-60) and short chains (GFn, n = 2-8) fructosaccharides provides bifidobacteria with exclusive nutrition along the entire length of the colon, which provides: • Prebiotic effect. With monotherapy - multiple growth of the intestinal normal flora. • The effect of dietary (dietary) fiber. Promotes increased stool mass and frequency of bowel movements • Increased body resistance and improved well-being. • Significant increase in calcium absorption. Flat-oval tablet from white to lemon-yellow color.
General description:
Dietary supplement (BAA) to food
Special conditions:
In accordance with the Conclusion of the Scientific Society "Microbiota" (Chicherin I.Yu., Pogorelsky I.P., Lundovskikh I.A., Darmov I.V., Shabalina M.R., Podvolotsky A.S. Comparative experimental evaluation of the effectiveness of modern probiotics, prebiotics, synbiotics and metabiotics in the correction of intestinal microbiocenosis disorders in animals with antibiotic-associated dysbiosis // Experimental and Clinical Gastroenterology, 2016, No. 7 (131), pp. 106-120) among the top drugs with similar indications for use and released for the period of 2016, the prebiotic Stimbifid showed the maximum efficiency in the rate of recovery of the intestinal microbiota.
Indications:
-dysbacteriosis (dysbiosis) of the intestine and their prevention during the period of taking antibiotics and after it;
- acute and chronic intestinal infections and their prevention;
- allergic diseases and immunodeficiency states;
-increasing the resistance of the mucous membranes to inflammatory factors;
- normalization of lipid metabolism and body weight;
-chronic colitis;
- functional disorders of the intestines;
- improving the absorption of calcium, prevention of osteoporosis.
Application methods:
Adults take 2 tablets 3 times a day with meals. Duration of admission is 1-2 months.